TISATO, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 4.225
NA - Nord America 2.451
SA - Sud America 833
EU - Europa 726
AF - Africa 82
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.323
Nazione #
US - Stati Uniti d'America 2.283
SG - Singapore 1.799
CN - Cina 915
BR - Brasile 657
HK - Hong Kong 457
VN - Vietnam 420
FR - Francia 274
KR - Corea 201
IT - Italia 156
BD - Bangladesh 94
GB - Regno Unito 77
CA - Canada 76
IN - India 68
JP - Giappone 59
AR - Argentina 55
DE - Germania 41
ID - Indonesia 35
EC - Ecuador 31
FI - Finlandia 31
CO - Colombia 30
NL - Olanda 27
MX - Messico 26
IL - Israele 25
VE - Venezuela 18
ZA - Sudafrica 18
ES - Italia 17
IQ - Iraq 16
PH - Filippine 16
PY - Paraguay 15
MY - Malesia 14
TN - Tunisia 14
BE - Belgio 13
IR - Iran 12
PK - Pakistan 12
RU - Federazione Russa 12
UA - Ucraina 12
EG - Egitto 11
SA - Arabia Saudita 11
AZ - Azerbaigian 10
CR - Costa Rica 10
NI - Nicaragua 10
UZ - Uzbekistan 10
CL - Cile 9
JM - Giamaica 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
MA - Marocco 8
PL - Polonia 8
TR - Turchia 8
UY - Uruguay 8
GR - Grecia 7
HN - Honduras 7
PA - Panama 7
AT - Austria 6
KE - Kenya 6
AL - Albania 5
KZ - Kazakistan 5
NP - Nepal 5
DK - Danimarca 4
DZ - Algeria 4
GP - Guadalupe 4
JO - Giordania 4
LT - Lituania 4
SE - Svezia 4
SI - Slovenia 4
SN - Senegal 4
CH - Svizzera 3
CI - Costa d'Avorio 3
GT - Guatemala 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
PR - Porto Rico 3
SC - Seychelles 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AG - Antigua e Barbuda 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BZ - Belize 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CY - Cipro 1
GA - Gabon 1
GN - Guinea 1
Totale 8.305
Città #
Singapore 1.079
Santa Clara 526
Hefei 455
Hong Kong 454
San Jose 355
Lauterbourg 209
Seoul 198
Ashburn 167
Ho Chi Minh City 145
Beijing 121
Hanoi 95
Los Angeles 73
Dallas 70
Guangzhou 46
São Paulo 43
New York 33
Tokyo 32
Rio de Janeiro 29
Helsinki 27
Buffalo 25
Minamishinagawa 24
Haiphong 20
Milan 20
Frankfurt am Main 19
Orem 18
Belo Horizonte 17
Bengaluru 17
Toronto 16
Da Nang 15
London 14
Phoenix 14
Atlanta 13
Brasília 13
Brooklyn 13
Brussels 13
Rome 13
Biên Hòa 12
Philadelphia 12
Curitiba 11
Montreal 11
Quito 11
Bogotá 10
Can Tho 10
Council Bluffs 10
Figino 10
Tehran 10
Baku 9
Campinas 9
Chicago 9
Dhaka 9
Miami 9
Padua 9
San José 9
Tashkent 9
Houston 8
Kuala Lumpur 8
Managua 8
Memphis 8
Naples 8
New Delhi 8
Ottawa 8
Porto Alegre 8
Salvador 8
The Bronx 8
Asunción 7
Athens 7
Cleveland 7
Guayaquil 7
Johannesburg 7
Manaus 7
Newark 7
Quận Một 7
San Diego 7
São José dos Campos 7
Uberlândia 7
Catania 6
Contagem 6
Detroit 6
Florence 6
Fortaleza 6
Jacksonville 6
Lima 6
Lấp Vò 6
Nam Định 6
Ninh Bình 6
Panama City 6
Phủ Lý 6
Portsmouth 6
Ribeirão Preto 6
Turin 6
Warsaw 6
Amsterdam 5
Boardman 5
Bình Dương 5
Cape Town 5
Charlotte 5
Chennai 5
Denver 5
Erbil 5
Formosa 5
Totale 4.918
Nome #
Copper(I) and copper(II) adducts detected under ESI-MS conditions during the study of cytotoxic phosphino Cu(I) complexes. 86
Phthalates and heavy metals as endocrine disruptors in food: A study on pre-packed coffee products 80
Uncommon Anionic Dioxorhenium(V) and Neutral Monooxorhenium(V) Mixed-Ligand Complexes Containing Heterofunctionalized Phosphine Ligands: Syntheses and Structural Characterization 77
New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity 76
Synthesis and characterization of novel 99-technetium(III) phosphine complexes. HPLC characterization and rat biodistribution of the Tc-99m analogs 76
Technetium(V) and rhenium(V) complexes with Schiff-base ligands containing the ONNNO donor atom set. Crystal structure of [N,N?-3-azapentane-1,5-diylbis(salicylideneiminato)(3-)-O,O',N, N',N'']-oxotechnetium(V) 73
From phosphines to water soluble carbenes: synthesis and biological investigation of 11th group metal complexes 72
SYNTHESES AND STRUCTURAL CHARACTERIZATIONS OF 6-COORDINATE OXO-M(V) COMPLEXES (M=TC, RE) CONTAINING A TETRADENTATE P2N2-PHOSPHINO-AMIDO LIGAND 72
Interaction products of cytotoxic Cu(I) complexes with different solvent mixtures: an electrospray ionization mass spectrometry and density functional theory study 71
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 69
Relationship Between ESI(+)-MS Behavior and Cytotoxic Activity of [MI(P)4]+-type Complexes (M = Cu, Ag, Au; P = Tertiary Phosphane)" 66
Novel TcP3X3 (XS, O) cores in Tc(III) chemistry 65
New approach to the chemistry of technetium(V) and rhenium(V) phenylimido complexes: novel [M(NPh)PNP]3+ metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds 64
Synthesis, characterization and crystal structure of oxobis(p-thiocresolato)terpyridinerhenium(V), a new cationic, six-coordinate thiolato complex of rhenium 63
Synthesis and characterization of the bis(trithioperoxybenzoate) (dithiobenzoate) rhenium( III) hetero complex 62
Gold nanorods - copper(I) complexes conjugates as anticancer drug-delivery system 61
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand) 60
Structure of [Cu(DAPTA)4]+ complex in extremely diluted aqueous solution 59
Phosphanyl-amino complexes of nickel(II): Synthesis and structure 57
Reactivity of Al(III) with membrane phospholipids: A NMR approach 57
Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase 56
Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity 55
Copper(I) heteroleptic 3+1 complexes: ligand effect on their in vitro cytotoxicity 54
Neutral and charged copper(I) complexes on hydrophilic gold nanoparticles and nanorods: loading and structural studies for biomedical applications 54
ESI-MSn study of the interaction products of cytotoxic phosphino copper(I) complexes with model peptides 53
Experimental Evidences of The Presence of Bimolecular Caffeine/Catechin Complexes in Green Tea Extracts 52
Metabolomic fingerprinting of plant extracts 52
Synthesis, Characterization and Crystal Structure of the Water Soluble Copper(I) Complex with Trisulfonated Triphenylphosphine 52
From tetrahedrical homoleptic phosphino copper (I) complexes [CuP4]+ to low coordinated species: effect on the antiproliferative activity 52
Coordinative unsaturated CuI entities are crucial intermediates governing cell internalization of copper. A combined experimental ESI-MS and DFT study. 51
Copper(I) complexes with phosphines P(p-OCH3-Ph)2CH2OH and P(p-OCH3-Ph)2CH2SarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitroantiproliferative activity 50
Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications 50
Syntheses and characterization of new rhenium(V)-oxo complexes containing N,N,O-heteroscorpionate ligands 49
Synthesis, reactivity and cytotoxic properties of water soluble coinage metal N-Heterocyclic Carbene complexes 49
Co-ordination of (o-aminophenyl)diphenylphosphine in complexes containing the [Mv = O]3+ (M = Tc or Re) core 49
Synthesis and characterization of novel tetrahedral copper(I) complexes comprising tridentate PNP-aminodiphosphines and tetradentate PN(X)P-substituted aminodiphosphines (X = O, S) 49
Copper Complexes as Anticancer Agents 49
Radioactive Transition Metal Nitride Hetero-Complex 48
Evidence of non-covalent complexes in some natural extracts: Ceylon tea and Mate extracts 48
Synthesis and Characterization of Mixed-Ligand Zn(II) and Cu(II) Complexes Including Polyamines and Dicyano-dithiolate(2-): In vitro Cytotoxic Activity of Cu(II) Compounds 48
Electrospray mass spectrometry, mixed nitrido-Tc heterocomplexes and nuclear medicine 47
Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): Cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands 47
In vitro evaluation of antileishmanial activity of copper (I) complexes 47
Syntheses and characterisation of rhenium-(III) and -(V) complexes containing aminophosphine ligands. Crystal structures of [Re-V(OCl2)(OMe)L] and [Re-III(Cl3L)(PPh3)], L equals o-(diphenylphosphino)-N,N'-dimethylaniline 47
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines 46
Polydentate phosphinoamine ligands: a class of efficient chelating agents for the stabilization of various technetium(V) and rhenium(V) cores 46
[MI(HB(pz)3)(P)] complexes (P = monodentate phosphine): comparison of the antiproliferative activity of silver and copper "3+1" mixed-ligand compounds 46
Electrospray ionization in the study of the interactions between cytotoxic phosphino Cu(i) complexes and selected amino acids and GlyGlyHis peptide model 46
Contamination of dry foods with trimethyldiphenylmethanes by migration from recycled paper and board packaging 46
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 46
Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance 45
Phosphine-copper(I) complexes as anticancer agents: design, synthesis, and physicochemical characterization. Part I 45
Electrospray ionization multi-stage mass spectrometric study of the interaction products of the cytotoxic complex [Cu(thp)4][PF6] with methionine-rich model peptides 45
Phosphino copper(I) complexes as potential anticancer agents: physico-chemical and biological properties 44
In vitro antitumor activity of water-soluble copper(I) complexes with diimine and monodentate phosphine ligands 44
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET : physico-chemical identification of by-products and degradation species 43
A NEW PHASE OF BIS[2-(DIPHENYLPHOSPHINO-K-P-PHENYLAZANIDO-K-N](ETHANOLATO)(OXO)-RHENIUM(V) 43
Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals 43
Mixed-Ligand Rhenium-188 Complexes with Tetradentate/Monodentate NS3/P ('4 + 1') Coordination: Relation of Structure with Antioxidation Stability 42
Phosphine copper(I) complexes as anticancer agents: biological characterization. Part II 42
Rhenium(I) Tricarbonyl Complexes with (2-Hydroxyphenyl)diphenylphosphine as PO Bidentate Ligand 42
Electrospray ionization study of tricarbonyl fac-[Re(CO)3(PO)(X)]- type complexes: influence of ancillary co-ligands in the release of carbon monoxide 42
Cu(I) Complexes Bearing Phosphines Derived From Hydrophilic SarGly -Physicochemical and Biological Characteristics 42
Synthesis and characterization of Oxorhenium(V) Complexes Containing o-diphenylphosphinophenolato and monothiolato lingands 41
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 41
Low-Valent Technetium Complexes with Aminodiphosphines 41
ESI-MSn study of the interaction products of a cytotoxic phosphino copper(I) complex with methionine-rich peptides 41
Copper in Diseases and Treatments, and Copper-Based Anticancer Strategies 40
Synthesis and characterization of mixed-ligand Zn(II) and Cu(II) complexes including polyamines and dicyanodithiolate: in vitro cytotoxic activity of Cu(II) compounds 40
Cu(I) and Ag(I) complex formation with the hydrophilic phosphine 1, 3, 5 triaza-7-phosphadamantane in different ionic media. How to estimate the effect of a complexing medium 40
Evaluation of anti-Leishmania activity induced by silver metal complexes against leishmania amazonensis and leishmanial guyanensis 39
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 39
Synthetic routes to mono-N-functionalized P2N2-ligands 39
On the presence of non-covalent complexes in natural extracts 39
Tc and Re Nitrido Asymmetrical Heterocomplexes. A '2+2' Approach 38
Synthesis of new copper(I) complexes with hydrophilic aminomethylphosphines 37
The [99mTc(N)(PNP)]2+ Metal Fragment : A Technetium-Nitrido Synthon for use with Biologically Active Molecules. The N-(2-Methoxyphenyl)piperazyl-cysteine Analogues as Examples. 37
Technetium coordination chemistry; development of new backbones for 99mTc radiopharmaceuticals 36
Reactivity of Bi- and Tetra-Dentate Phosphinoamine Ligands Toward Technetium and Rhenium 36
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines 36
Syntheses and characterization of amino and amido-imido technetium(V) and rhenium(V) complexes with (o-aminophenyl)diphenylphosphine-N,P. Crystal structures of [TcNCl{PPh2(C6H4NH2-2)} 2]Cl·MeCN and [Re{PPh2(C6H4N-2)}Cl2{PPh 2(C6H4NH-2}] 36
[Cu(thp)4]n[X]-n compounds for the treatment of a broad range of human solid tumors, including refractory tumors. 35
Complessi azoturo dissimmetrici monocationici di metalli di transizione radioattivi 35
ESI in the study of the interactions between phosphino-Cu(I) complexes and Cu(II) salts with model peptides relevant to human copper transporters (hCTR) 35
Technetium and Rhenium in Five-Coordinate Symmetrical and Dissymmetrical Nitrido Complexes with Alkyl Phosphino-thiol Ligands. Synthesis and Structural Characterization 35
Mixed ligand Tc-and Re-nitrido complexes for radiolabelling bioactive molecules 35
Syntheses and reactivity of sulphur rich Re(III) and Tc(III) complexes containing trithioperoxybenzoate, dithiobenzoate and dithiocarbamate ligands 35
A mass spectrometric investigation of a series of [ReOX(PY)(2)] complexes containing bidentate phosphinophenolate and phosphinoamine ligands 35
Thermodynamic stability and structure in aqueous solution of the [Cu (PTA)4]+ complex (PTA=aminophosphine-1,3, 5-triaza-7-phosphaadamantane) 35
(2-Hydroxyphenyl)diphenylphosphine as fac-[Re/Tc-99m(CO)(3)](+)-ligand 35
ESI/MSn in the structural characterisation of some nitrido-Re heterocomplexes 35
Alternative Synthesis of Aminodiphosphines 35
ESI(+)MS and DFT studies on the internalization of copper in tumour cells: copper(II)/copper(I) interplay at the hCtr1 substrate 35
The relationship between the electrospray ionization behaviour and biological activity of some phosphino Cu(I) complexes 35
'Complessi carbenici N-eterociclici simmetrici e asimmetrici dei metalli da conio: sintesi, citotossicità e studi in soluzione 34
Neutral fac-[Re(I)/Tc-99m(I)(CO)(3)](+)-complexes with the new PO/L-donor system 34
Trigonal-Bypyramidal Tc(V) and Tc(III) Complexes with Mixed S,P-Bidentate Phosphine-Thiols 33
Neutral and cationic nickel (II) complexes of phosphino-amines: [NiCl2(PMe2Ph)(PNMe2)] and [NiCl(PMe2Ph) (PNMe2)]PF6 (PNMe2 = N,N?-dimethyl-2-(diphenylphosphino) aniline) 33
Synthesis and characterization of [dichloro[hydrotris(1-pyrazolyl)borate]sulfido-technetium(V)] and [bis-(u-ethane-1,2-dithiolato)-bis-(ethene-1,2-dithiolato)-technetium(IV)] complexes. The first evidence of a terminal Tc=S multiple bond 33
Novel symmetrical and non-symmetrical 11th group-NHC complexes: synthesis, citotoxicity and solution behaviour. 33
Totale 4.763
Categoria #
all - tutte 34.684
article - articoli 21.539
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 672
Totale 56.895


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202451 0 0 0 0 0 0 0 0 2 0 48 1
2024/20252.667 8 19 220 134 428 141 36 71 35 53 806 716
2025/20264.560 270 457 500 755 791 162 674 203 217 200 128 203
2026/20271.045 241 186 618 0 0 0 0 0 0 0 0 0
Totale 8.323